| AKEBIA THERAPEUTICS |
| USA |
| Gesundheit |
| US00972D1054 / A1XF0S |
| AX9 (Frankfurt) / AKBA (NASDAQ) |
| FRA:AX9, ETR:AX9, AX9:GR, NASDAQ:AKBA |
| - |
| https://akebia.com/ |
|
Akebia Therapeutics Inc. is a biopharmaceutical co..
>Volltext.. |
| 721.45 Mio. EUR |
| 783.6 Mio. EUR |
| 174.87 Mio. EUR |
| 20.89 Mio. EUR |
| -31.32 Mio. EUR |
| -0.15 EUR |
| 180.73 Mio. EUR |
| 117.86 Mio. EUR |
| -2.06 Mio. EUR |
| 1.16 |
| 6.16% |
| 17.97% |
| - |
| - |
| - |
| - |
| AKEBIA |
| 29.10.25 |